Activity Components from <i>Gynostemma pentaphyllum</i> for Preventing Hepatic Fibrosis and of Its Molecular Targets by Network Pharmacology Approach
Hepatic fibrosis would develop into cirrhosis or cancer without treating. Hence, it is necessary to study the mechanism and prevention methods for hepatic fibrosis. <i>Gynostemma pentaphyllum</i> is a traditional medicinal material with a high medicinal and health value. In this study, n...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/26/10/3006 |
id |
doaj-f759b30c76024a209ff08225d06597c5 |
---|---|
record_format |
Article |
spelling |
doaj-f759b30c76024a209ff08225d06597c52021-06-01T00:24:22ZengMDPI AGMolecules1420-30492021-05-01263006300610.3390/molecules26103006Activity Components from <i>Gynostemma pentaphyllum</i> for Preventing Hepatic Fibrosis and of Its Molecular Targets by Network Pharmacology ApproachYumeng Zhang0Guohui Shi1Zhonghua Luo2Jiewen Wang3Shao Wu4Xiaoshu Zhang5Yuqing Zhao6School of Functional Food and Wine, Shenyang Pharmaceutical University, Shenyang 110016, ChinaSchool of Functional Food and Wine, Shenyang Pharmaceutical University, Shenyang 110016, ChinaSchool of Functional Food and Wine, Shenyang Pharmaceutical University, Shenyang 110016, ChinaSchool of Functional Food and Wine, Shenyang Pharmaceutical University, Shenyang 110016, ChinaSchool of Functional Food and Wine, Shenyang Pharmaceutical University, Shenyang 110016, ChinaSchool of Functional Food and Wine, Shenyang Pharmaceutical University, Shenyang 110016, ChinaSchool of Functional Food and Wine, Shenyang Pharmaceutical University, Shenyang 110016, ChinaHepatic fibrosis would develop into cirrhosis or cancer without treating. Hence, it is necessary to study the mechanism and prevention methods for hepatic fibrosis. <i>Gynostemma pentaphyllum</i> is a traditional medicinal material with a high medicinal and health value. In this study, nineteen compounds obtained from <i>G. pentaphyllum</i> were qualitative and quantitative by HPLC-FT-ICR MS and HPLC-UV, respectively. Among them, the total content of 19 gypenosides accurately quantified reaches 72.21 mg/g and their anti-proliferation against t-HSC/Cl-6 cells indicated compound <b>19</b> performed better activity (IC50: 28.1 ± 2.0 μM) than the other compounds. Further network pharmacology study demonstrated that compound <b>19</b> mainly plays an anti-fibrosis role by regulating the EGFR signaling pathway, and the PI3K–Akt signaling pathway. Overall, the verification result indicated that compound <b>19</b> appeared to be nontoxic to LO2, was able to modulate the PI3K/Akt signal, led to subG1 cells cycle arrest and the activation of mitochondrial-mediated apoptosis of t-HSC/Cl-6 cells for anti-hepatic fibrosis.https://www.mdpi.com/1420-3049/26/10/3006<i>G. pentaphyllum</i>hepatic fibrosisnetwork pharmacologyPI3K/Akt signaling pathway |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yumeng Zhang Guohui Shi Zhonghua Luo Jiewen Wang Shao Wu Xiaoshu Zhang Yuqing Zhao |
spellingShingle |
Yumeng Zhang Guohui Shi Zhonghua Luo Jiewen Wang Shao Wu Xiaoshu Zhang Yuqing Zhao Activity Components from <i>Gynostemma pentaphyllum</i> for Preventing Hepatic Fibrosis and of Its Molecular Targets by Network Pharmacology Approach Molecules <i>G. pentaphyllum</i> hepatic fibrosis network pharmacology PI3K/Akt signaling pathway |
author_facet |
Yumeng Zhang Guohui Shi Zhonghua Luo Jiewen Wang Shao Wu Xiaoshu Zhang Yuqing Zhao |
author_sort |
Yumeng Zhang |
title |
Activity Components from <i>Gynostemma pentaphyllum</i> for Preventing Hepatic Fibrosis and of Its Molecular Targets by Network Pharmacology Approach |
title_short |
Activity Components from <i>Gynostemma pentaphyllum</i> for Preventing Hepatic Fibrosis and of Its Molecular Targets by Network Pharmacology Approach |
title_full |
Activity Components from <i>Gynostemma pentaphyllum</i> for Preventing Hepatic Fibrosis and of Its Molecular Targets by Network Pharmacology Approach |
title_fullStr |
Activity Components from <i>Gynostemma pentaphyllum</i> for Preventing Hepatic Fibrosis and of Its Molecular Targets by Network Pharmacology Approach |
title_full_unstemmed |
Activity Components from <i>Gynostemma pentaphyllum</i> for Preventing Hepatic Fibrosis and of Its Molecular Targets by Network Pharmacology Approach |
title_sort |
activity components from <i>gynostemma pentaphyllum</i> for preventing hepatic fibrosis and of its molecular targets by network pharmacology approach |
publisher |
MDPI AG |
series |
Molecules |
issn |
1420-3049 |
publishDate |
2021-05-01 |
description |
Hepatic fibrosis would develop into cirrhosis or cancer without treating. Hence, it is necessary to study the mechanism and prevention methods for hepatic fibrosis. <i>Gynostemma pentaphyllum</i> is a traditional medicinal material with a high medicinal and health value. In this study, nineteen compounds obtained from <i>G. pentaphyllum</i> were qualitative and quantitative by HPLC-FT-ICR MS and HPLC-UV, respectively. Among them, the total content of 19 gypenosides accurately quantified reaches 72.21 mg/g and their anti-proliferation against t-HSC/Cl-6 cells indicated compound <b>19</b> performed better activity (IC50: 28.1 ± 2.0 μM) than the other compounds. Further network pharmacology study demonstrated that compound <b>19</b> mainly plays an anti-fibrosis role by regulating the EGFR signaling pathway, and the PI3K–Akt signaling pathway. Overall, the verification result indicated that compound <b>19</b> appeared to be nontoxic to LO2, was able to modulate the PI3K/Akt signal, led to subG1 cells cycle arrest and the activation of mitochondrial-mediated apoptosis of t-HSC/Cl-6 cells for anti-hepatic fibrosis. |
topic |
<i>G. pentaphyllum</i> hepatic fibrosis network pharmacology PI3K/Akt signaling pathway |
url |
https://www.mdpi.com/1420-3049/26/10/3006 |
work_keys_str_mv |
AT yumengzhang activitycomponentsfromigynostemmapentaphyllumiforpreventinghepaticfibrosisandofitsmoleculartargetsbynetworkpharmacologyapproach AT guohuishi activitycomponentsfromigynostemmapentaphyllumiforpreventinghepaticfibrosisandofitsmoleculartargetsbynetworkpharmacologyapproach AT zhonghualuo activitycomponentsfromigynostemmapentaphyllumiforpreventinghepaticfibrosisandofitsmoleculartargetsbynetworkpharmacologyapproach AT jiewenwang activitycomponentsfromigynostemmapentaphyllumiforpreventinghepaticfibrosisandofitsmoleculartargetsbynetworkpharmacologyapproach AT shaowu activitycomponentsfromigynostemmapentaphyllumiforpreventinghepaticfibrosisandofitsmoleculartargetsbynetworkpharmacologyapproach AT xiaoshuzhang activitycomponentsfromigynostemmapentaphyllumiforpreventinghepaticfibrosisandofitsmoleculartargetsbynetworkpharmacologyapproach AT yuqingzhao activitycomponentsfromigynostemmapentaphyllumiforpreventinghepaticfibrosisandofitsmoleculartargetsbynetworkpharmacologyapproach |
_version_ |
1721415053020758016 |